HEMOGENYX PHARMPLC (Germany) Probability of Future Stock Price Finishing Under 2.89
| 5HU Stock | EUR 3.79 0.01 0.26% |
HEMOGENYX |
HEMOGENYX PHARMPLC Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of HEMOGENYX PHARMPLC for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for HEMOGENYX PHARMPLC can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| HEMOGENYX PHARMPLC is way too risky over 90 days horizon | |
| HEMOGENYX PHARMPLC appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (2.08 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| HEMOGENYX PHARMPLC LS 01 has accumulated about 1.81 M in cash with (1.8 M) of positive cash flow from operations. | |
| Roughly 15.0% of the company shares are owned by insiders or employees |
HEMOGENYX PHARMPLC Technical Analysis
HEMOGENYX PHARMPLC's future price can be derived by breaking down and analyzing its technical indicators over time. HEMOGENYX Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of HEMOGENYX PHARMPLC LS 01. In general, you should focus on analyzing HEMOGENYX Stock price patterns and their correlations with different microeconomic environments and drivers.
HEMOGENYX PHARMPLC Predictive Forecast Models
HEMOGENYX PHARMPLC's time-series forecasting models is one of many HEMOGENYX PHARMPLC's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary HEMOGENYX PHARMPLC's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about HEMOGENYX PHARMPLC
Checking the ongoing alerts about HEMOGENYX PHARMPLC for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for HEMOGENYX PHARMPLC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| HEMOGENYX PHARMPLC is way too risky over 90 days horizon | |
| HEMOGENYX PHARMPLC appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (2.08 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| HEMOGENYX PHARMPLC LS 01 has accumulated about 1.81 M in cash with (1.8 M) of positive cash flow from operations. | |
| Roughly 15.0% of the company shares are owned by insiders or employees |
Other Information on Investing in HEMOGENYX Stock
HEMOGENYX PHARMPLC financial ratios help investors to determine whether HEMOGENYX Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HEMOGENYX with respect to the benefits of owning HEMOGENYX PHARMPLC security.